Research and Markets: Global Musculoskeletal Drugs Market 2011-2015 – The Global Musculoskeletal Drugs Market to Grow …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ctb96m/global_musculoskel) has announced the addition of the "Global Musculoskeletal Drugs Market 2011-2015" report to their offering.

One of the key factors contributing to this market growth is the increasing prevalence of musculoskeletal diseases. The Global Musculoskeletal Drugs market has also been witnessing the increasing use of drugs for treatment of multiple diseases. However, the upcoming patent expiries of top-selling drugs could pose a challenge to the growth of this market.

Key vendors dominating this market space include Abbott Laboratories Inc., Eli Lilly and Co., Johnson and Johnson Services Inc., and Pfizer Inc.

Commenting on the report, an analyst from TechNavio's Healthcare team said; Patients suffering from musculoskeletal diseases related to central nervous system disorders and autoimmune disorders have been using steroids and immunosuppressants. However, these medications cause serious side effects because they are chemically synthesized. Hence, patients are turning to biologic drugs that not only cause fewer side effects but are also more effective in the treatment of musculoskeletal diseases. Moreover, there has been an increase in the number of biologic drugs entering the Global Musculoskeletal Drugs market.

According to the report, developing countries such as India, China, and those in East Asia and Latin America are the world's fastest-growing markets, and they are expected to emerge as one the major revenue contributors to the Global Musculoskeletal Drugs market during the next decade. These countries are expected to grow three times faster than the developed markets, and they are driven by many factors such as evolving demographics, rising income, modernization of health systems, and the increasing demand for the treatment of chronic diseases. Thus, the market in the APAC countries is expected to post the highest growth rate in the next few years.

Further, the report also discusses that the availability of alternative treatments for musculoskeletal diseases is a major challenge in the Global Musculoskeletal Drugs market.

For more information visit http://www.researchandmarkets.com/research/ctb96m/global_musculoskel

Link:
Research and Markets: Global Musculoskeletal Drugs Market 2011-2015 - The Global Musculoskeletal Drugs Market to Grow ...